Homology sails with same captains in different seats; Ex-Harpoon chief weathers the Storm at UK biotech
After a multi-year run as co-workers at Shire Pharmaceuticals, Arthur Tzianabos and Albert Seymour got the band back together in 2016 as two of the early-days employees at Homology Medicines.
Tzianabos as CEO and Seymour as science chief of the genetic medicine-focused biotech “was not really ready for prime time,” in the words of Seymour. The plan from the start was to have Seymour assume the chief executive duties once the biotech was fully in the clinic with multiple programs to account for.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
